New consulting services provide expert guidance on pharmaceutical containment, delivery systems, analytical testing strategies and regulatory readiness.
EDEN PRAIRIE, Minn., Nov. 17, 2026 /PRNewswire/ -- DDL, a third-party testing laboratory specializing in medical device and pharmaceutical packaging, combination products, and materials testing, announced today it has launched a new Pharmaceutical Consulting Services program to help pharmaceutical and drug delivery companies navigate complex development challenges, reduce risk and accelerate product development.
The new consulting services provide expert guidance across pharmaceutical primary packaging, containment and delivery systems, and combination products. By integrating technical consulting with DDL's established laboratory testing capabilities, the services help companies develop effective, phase-appropriate testing strategies and address potential challenges before they lead to costly rework or delays.
"Decisions made early in pharmaceutical packaging and drug delivery development can have significant implications for product performance, quality and regulatory success," said Jennifer Riter, Vice President of Analytical Testing Services at DDL. "Our goal is to help customers make informed technical decisions, identify potential risks and develop testing strategies that support successful product development from initial concept through commercialization."
DDL's Pharmaceutical Consulting Services include:
- Combination Product, Containment and Delivery System Strategy: Guidance on primary packaging, component selection and delivery system development.
- Analytical and Phase-Appropriate Test Strategy: Development of testing programs aligned with product requirements, development milestones and regulatory expectations.
- Performance and Design Verification Strategy: Support for establishing performance requirements and appropriate verification approaches.
- Stability, Shelf-Life and Distribution Strategy: Guidance on stability studies, packaging performance and distribution testing.
- Program Review, Troubleshooting and Lifecycle Support: Gap assessments, technical reviews and remediation strategies to address development challenges and support ongoing product performance.
DDL's pharmaceutical consulting services are led by Riter, who brings nearly three decades of experience in pharmaceutical primary containment, drug delivery systems, analytical services and combination product development. Her background includes senior global leadership roles overseeing analytical and development organizations supporting injectable, nasal and inhalation drug delivery technologies.
For further information regarding DDL's GMP testing and pharmaceutical consulting services, or to request a quote, please visit www.DDLtesting.com or contact us directly at 800-229-4235.
About DDL
DDL is an independent third party testing facility that offers expertise in medical device, combination products, materials and package testing primarily serving the life sciences industry. DDL's testing laboratories are located in Eden Prairie, MN, Minnetonka, MN, Irvine, CA and Edison, NJ. Visit www.DDLTesting.com for more information about the testing services offered by DDL.
SOURCE DDL, INC.


Share this article